biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Time Warp

<< Previous

Bullboard Posts

Next >>

Comment by unclepiemanon Nov 09, 2022 6:27pm

126 Views

Post# 35086854

RE:RE:RE:RE:RE:RE:RE:Time Warp

You are right.

you are a moronic sociopathic idiot.

really, a joke, and no one should take a single word you say seriously.

No one cares about any of the lies and inaccuracies you've shared, your not being paid by BTI anymore, you have no shares, why are you still here?

go away!

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec